Summary
A wide variety of drugs or combinations of drugs have the potential to form bezoars. In the majority of patients presenting with bezoars there is a clear predisposing factor. This article highlights those drugs or groups of drugs which have been implicated in bezoar formation. Although bezoars are rare, it is important that the clinician is aware of the possibility of their development, particularly in susceptible individuals. This is because bezoars often develop in the elderly and in those with serious coexistent disease. They may be difficult to diagnose and recourse to laparotomy is frequently required to treat them. As a result, they are associated with a significant morbidity and mortality.
Similar content being viewed by others
References
Carrougher JG, Barrilleaux CN. Esophageal bezoars: the sucralith. Crit Care Med 1991; 19: 837–9.
Ahn YH, Maturu P, Steinheber FU, et al. Association of diabetes mellitus with gastric bezoar formation. Arch Intern Med 1987; 147: 527–8.
Korenman MD, Stubbs MB, Fish JC. Intestinal obstruction from medication bezoars. JAMA 1978; 240 (1): 54–5.
Brettschneider L, Monafo W, Osborne DP. Intestinal obstruction due to antacid gels. Gastroenterology 1965; 49 (3): 291–4.
Sandeman DR, Clements MR, Perrins EJ. Oesophageal obstruction due to hydroscopic gum laxative [letter]. Lancet 1980; i: 364–5.
Sussman S, Goldberg RP, Glotzer DJ. Aluminum hydroxide gel bezoar: CT diagnosis. J Can Assoc Radiol 1985; 36: 148–9.
Diettrich NA, Gau FC. Postgastrectomy phytobezoars — endoscopic diagnosis and treatment. Arch Surg 1985; 120 (4): 432–5.
Robles R, Parrilla P, Escamilla C, et al. Gastrointestinal bezoars. Br J Surg 1994; 81: 1000–1.
Gebhard RL, Albrecht J. The diet pill that worked [letter]. N Engl J Med 1990; 322: 702.
Angueira C, Kadakia S. Esophageal and duodenal bezoars from Perdiem [letter]. Gastrointest Endosc 1993; 39: 110–1.
Anderson W, Weatherstone G, Veal C. Esophageal medication bezoar in a patient receiving enterai feedings and sucralfate. Am J Gastroenterol 1989; 84: 205–6.
Grosskopf I, Streifler J, Garty M, et al. Esophageal bezoar in progressive systemic sclerosis [letter]. J Clin Gastroenterol 1986; 8: 695–6.
Lange V. Gastric phytobezoar: an endoscopic technique for removal. Endoscopy 1986; 18: 195–6.
Mamel JJ. Bezoar of the esophagus occurring in achalasia. Gastrointest Endosc 1984; 30: 317–8.
Tsianos EB, Drosos AA. Gastroscopic removal of a phytobezoar formed in a patient with mixed connective tissue disease. Endoscopy 1988; 20: 122–3.
Algozzine GJ, Hill G, Scoggins WG, et al. Sucralfate bezoar. N Engl J Med 1983; 309: 1387.
Kuiper D. Gastric bezoar in a patient with myotonic dystrophy. Am J Dig Dis 1971; 16: 529–34.
Deutsch AA, Gutman H, Mor C, et al. Gastric cancer bezoar. J R Coll Surg Edinb 1987; 32: 165–6.
Schwab KS, Cheng EH. ‘Postgastrectomy’ bezoar secondary to gastric cancer. J Clin Gastroenterol 1993; 16: 45–7.
Van Thiel DH, deBeile RC, Painter TD, et al. Phytobezoar occurring as a complication of gastric carcinoma. Gastroenterology 1975; 68 (5 Pt 1): 1292–6.
Canivet B, Creisson G, Freychet P, et al. Fibre, diabetes, and risk of bezoar [letter]. Lancet 1980; ii (8199): 862.
Brady PG. Gastric phytobezoars consequent to delayed gastric emptying. Gastrointest Endosc 1978; 24: 159–61.
Calabuig R, Navarro S, Carrio I, et al. Gastric emptying and bezoars. Am J Surg 1989; 157: 287–90.
Tohdo H, Haruma K, Kitadai Y, et al. Gastric emptying and bezoars in Japanese. Report of five cases. Dig Dis Sci 1993; 38: 1422–5.
Potyk D. Intestinal obstruction from impacted antacid tablets. N Engl J Med 1970; 283: 134–45.
Townsend CM, Remmers AR, Sarles HE, et al. Intestinal obstruction from medication bezoar in patients with renal failure. N Engl J Med 1973; 20: 1058–9.
Shaffer JL, Higham C, Turnberg LA. Hazards of slow-release preparations in patients with bowel strictures [letter]. Lancet 1980; ii (8192): 487.
Huizinga WK, Nirmul D, Domingo Z, et al. Late presentation of small bowel injury — hypoproteinaemia, anaemia and obstruction. A report of 2 cases. S Afr Med J 1988; 73 (4): 251–2.
Thornley Brown D, Galla JH, Williams PD, et al. Lithium toxicity associated with a trichobezoar. Ann Intern Med 1992; 116: 739–40.
Buckley N, Dawson AH, Howarth D, et al. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust 1993; 158: 202–4.
Rankin RJ, Edwards IR. Overdose of sustained release verapamil [letter]. NZ Med J 1990; 103: 165.
Spiller HA, Meyers A, Ziemba T, et al. Delayed onset of cardiac arrhythmias from sustained release verapamil. Ann Emerg Med 1991; 20: 201–3.
Portuguez-Malavasi A, Aranda JV. Antacid bezoar in a newborn. Pediatrics 1979; 63: 679–80.
Nichols Jr TW. Phytobezoar formation: a new complication of cimetidine therapy. Ann Intern Med 1981; 95 (1): 70.
Hurley JK. Bowel obstruction occurring in a child during treatment with aluminium hydroxide gel. J Pediatr 1978; 92 (4): 592–3.
Nichols Jr TW. Cimetidine and phytobezoars [letter]. Lancet 1978; ii: 1263.
Burruss GL, Van Voorst SJ, Crawford AJ, et al. Small bowel obstruction from an antacid bezoar: a ranitidine-antacid interaction? South Med J 1986; 79: 917–8.
Frohna WJ. Metamucil bezoar: an unusual cause of small bowel obstruction [letter]. Am J Emerg Med 1992; 10: 393–5.
Perez Piqueras J, Silva C, Jaqueti J, et al. Endoscopic diagnosis and treatment of an esophageal bezoar resulting from bulk laxative ingestion. Endoscopy 1994; 26: 710.
Cohen MI, Winslow PR, Boley SJ. Intestinal obstruction associated with cholestyramine therapy. N Engl J Med 1969; 280 (23): 1285–6.
Lloyd-Still JD. Cholestyramine therapy and intestinal obstruction in infants. Pediatrics 1977; 59: 626–7.
Prisant LM, Carr AA, Bottini PB, et al. Nifedipine GITS (gastrointestinal therapeutic system) bezoar. Arch Intern Med 1991; 151: 1868–9.
Stack PE, Patel NR, Young MF, et al. Pharmacobezoars — the irony of the antidote: first case report of nifedipine XL bezoar. J Clin Gastroenterol 1994; 19: 264–5.
Shepherd MF. Bezoar formed by fragments of extended-release nifedipine tablets. Clin Pharm 1993; 12: 849–52.
Bernstein G, Jehle D, Bernaski E, et al. Failure of gastric emptying and charcoal administration in fatal sustained-release theophylline overdose: pharmacobezoar formation. Ann Emerg Med 1992; 21: 1388–90.
Shueke M, Mihas AA. Esophageal bezoar due to sucralfate [letter]. Endoscopy 1991; 23: 305–6.
Irgau I, Fulda GJ. Esophageal obstruction secondary to concretions of tube-feeding formula. Crit Care Med 1995; 23: 208–10.
McIvor AC, Meguid MM, Curtas S, et al. Intestinal obstruction from cecal bezoar; a complication of fiber-containing tube feedings. Nutrition 1990; 6: 115–7.
Hart R, Bernard L, Gholson C. Esophageal obstruction caused by sucralfate impaction. Gastrointest Endosc 1989; 35: 474.
Reddy AN. Sucralfate gastric bezoar. Gastroenterology 1986; 81: 149–50.
Baum J. Enteric-coated aspirin and the problem of gastric retention [letter]. J Rheumatol 1984; 11: 250–1.
Bogacz K, Caldron P. Enteric-coated aspirin bezoar: elevation of serum salicylate level by barium study. Case report and review of medical management. Am J Med 1987; 83: 783–6.
Landsman I, Bricker JT, Reid BS, et al. Emergency gastrotomy: treatment of choice for iron bezoar. J Pediatr Surg 1987; 22: 184–5.
Vickery RE. Unusual complication of excessive ingestion of vitamin C tablets. Int Surg 1973; 58: 422–3.
Hunt Fugate AK, Schmidt HJ. Cecal vitamin bezoar formation inducing abdominal discomfort. Ann Pharmacother 1992; 26: 485–7.
Hsu HH, Grove WE, Mindulzun R, et al. Gastric bezoar caused by lecithin: an unusual complication of health faddism. Am J Gastroenterol 1992; 87: 794–6.
Silbergleit R, Lee DC. Bowel obstruction and radiopaque vitamin B12 ‘pseudobezoar’ [letter]. Am J Emerg Med 1995; 13: 112–3.
Berman L, Briggs R, Thomas RM. Ion-exchange resin bezoar in a neonate. Clin Radiol 1986; 37: 297–8.
Fleisher DS. Hyperkalaemia in infants and children. J Pediatr 1961; 58 (4): 486–92.
Fildes RD, Springate JE, Jewett T, et al. Colonic intussusception secondary to a calcium phosphate bezoar in a child receiving calcium carbonate for hyperphosphatemia. J Pediatr Surg 1989; 24: 1195–7.
Ohlsson A, Hosking M. Complications following oral administration of exchange resins in extremely low-birth-weight infants. Eur J Pediatr 1987; 146: 571–4.
Ray MJ, Radin DR, Condie JD, et al. Charcoal bezoar. Small-bowel obstruction secondary to amitriptyline overdose therapy [published erratum appears in Dig Dis Sci 1988 Oct; 33 (10): 1344]. Dig Dis Sci 1988; 33: 106–7.
Schwartz HS. Acute meprobamate poisoning with gastrotomy and removal of drug-containing mass. N Engl J Med 1976; 1177–8.
Jenis EH, Payne RJ, Goldbaum LR. Acute meprobamate poisoning: a fatal case following a lucid interval. JAMA 1969; 207: 361–2.
Meprobamate and bezoar formation [letter]. Ann Emerg Med 1987; 16: 472–3.
Schwarzenberg SJ, Freese DK, Payne WD, et al. Gastric bezoar after hepatic transplantation. J Pediatr Gastroenterol Nutr 1989; 9: 119–22.
Davion T, Delamarre J, Reix N, et al. Gastric bezoar: another side effect of endoscopic variceal sclerotherapy. Scand J Gastroenterol 1989; 24: 818–20.
Meeroff JC, Squires PA, Grasman K. Gastric lupinoma: a new variety of phytobezoar. Am J Gastroenterol 1989; 84: 650–2.
Khoshoo V, Udall Jr JN. Meconium ileus equivalent in children and adults. Am J Gastroenterol 1994; 89: 153–7.
Mulherin D, Fitzgerald MX. Meconium ileus equivalent in association with nebulised ipratropium bromide in cystic fibrosis. Lancet 1990; 335 (8688): 552.
Mitchell EA, White PR, Elliot RB. Meconium ileus equivalent in a child with cystic fibrosis taking cimetidine. NZ Med J 1980; 92: 155–6.
Smyth RL, van Velzen D, Smyth AR, et al. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994; 343: 85–6.
Jones R, Franklin K, Spicer R, et al. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes [letter]. Lancet 1995; 346: 499.
van Velzen D. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes [letter]. Lancet 1995; 346 (8973): 499–500.
Walker Renard P. Update on the medicinal management of phytobezoars. Am J Gastroenterol 1993; 88: 1663–6.
Kuo JY, Mo LR, Tsai CC, et al. Endoscopic fragmentation of gastric phytobezoar by electrohydraulic lithotripsy. Gastrointest Endosc 1993; 39: 706–8.
Lubke HJ, Winkelmann RS, Berges W, et al. Gastric phytobezoar: endoscopic removal using the gallstone lithotripter. Z Gastroenterol 1988; 26: 393–6.
Benes J, Chmel J, Jodl J, et al. Treatment of a gastric bezoar by extracorporeal shock wave lithotripsy. Endoscopy 1991; 23: 346–8.
Buckley N, Dawson A. Whole-bowel irrigation for theophylline overdose [letter]. Ann Emerg Med 1993; 22: 1774.
Assalia A, Schein M, Kopelman D, et al. Therapeutic effect of oral Gastrografin in adhesive, partial small-bowel obstruction: a prospective randomized trial. Surgery 1994; 115: 433–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thompson, K.C., Iredale, J.P. Bezoars. Drug-Safety 14, 85–93 (1996). https://doi.org/10.2165/00002018-199614020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199614020-00003